>

MEETINGS / EVENTS

RSS

November 08 - 09 2014, 12:00 AM - 12:00 AM

ASA Quality Meeting 2014

January 23 - 25 2015, 12:00 AM - 12:00 AM

ASA PRACTICE MANAGEMENT 2015

February 07 - 08 2015, 12:00 AM - 12:00 AM

ASA Certificate in Business Administration 2015

>

FDA MEDWATCH ALERTS

October 20, 2014

Lidocaine HCI Injection, USP 10 MG Per ML, 30 ML Single-Dose, Preservative-Free, by Hospira: Recall - Particulate Matter

Summary:

FDA Medwatch Alert 10-20-14

October 16, 2014

FDA MedWatch - LifeCare Flexible Intravenous Solutions by Hospira, Inc.: Recall - Potential for Leakage

Summary:

FDA MedWatch LifeCare Flexible Intravenous Solutions by Hospira Inc

October 13, 2014

FDA MedWatch - CareFusion EnVe and ReVel Ventilators: Class 1 Recall - Power Connection Failure

Summary:

FDA MedWatch CareFusion EnVe and ReVel Ventilators

>

ASA FEATURED PRODUCT

Add this product to your shopping cart

Self-Education and Evaluation (SEE) Program

SKU: 30701-14CE

... Read more »

Single Copies, Member Price: $360

AHRQ Soliciting Comments on Pain Management Injections for Low Back Pain

Monday, February 24, 2014


The Agency for Healthcare Research and Quality (AHRQ) is soliciting feedback to a series of questions that will help the Agency assess the clinical utility of pain management injections for low back pain.  As part of AHRQ’s Technology Assessment Program, this information could be used by the Centers for Medicare and Medicaid Services to inform its national coverage decisions for the Medicare program as well as provide information to Medicare contractors.  Comments will be accepted until March 3, 2014. 

Submit comments to AHRQ.

Learn more about the Technology Assessment Program.  

Read AHRQ’s Topic Refinement Document on Pain Management Injection Therapies for Low-back Pain.


« Back to Washington Alerts